853921-69-4Relevant articles and documents
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
-
Page/Page column 7, (2010/11/08)
Novel dioxinoindazole compounds and dioxoloindazole compounds are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions of one
1-((S)-2-aminopropyl)-1H-indazol-6-ol: A potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity
May, Jesse A.,Dantanarayana, Anura P.,Zinke, Paul W.,McLaughlin, Marsha A.,Sharif, Najam A.
, p. 318 - 328 (2007/10/03)
Serotonin 5-HT2 receptor agonists have been identified as a potential new class of agents for the treatment of ocular hypertension and glaucoma. The initially reported tryptamine analogues displayed either poor solution stability, potent centra
SUBSTITUTED FURO[2,3-G] INDAZOLES FOR THE TREATMENT OF GLAUCOMA
-
Page/Page column 12, (2008/06/13)
Substituted furo[2,3-g]indazoles for lowering intraocular pressure and treating glaucoma are disclosed.